Antihypertensive effect of α- and β-adrenergic blockade in obese and lean hypertensive subjects

American Journal of Hypertension

Volumn 14, Issue 7 I, 2001, Pages 694-698

  Wofford, Marion R ^a,c   Anderson Jr, Douglas C ^b   Brown, C Andrew ^a   Jones, Daniel W ^a,c   Miller, Margaret E ^a   Hall, John E ^a,c  

^a UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

^b SOUTHWESTERN OKLAHOMA STATE UNIVERSITY   (United States)

^c UNIVERSITY OF MISSISSIPPI MEDICAL CENTER   (United States)

Author keywords

Blood pressure; Hypertension; Obesity; Sympathetic nervous system

Indexed keywords

ALPHA ADRENERGIC RECEPTOR; ATENOLOL; BETA ADRENERGIC RECEPTOR; DOXAZOSIN;

ADRENERGIC RECEPTOR BLOCKING; ADRENERGIC SYSTEM; ADULT; ANTIHYPERTENSIVE ACTIVITY; ARTICLE; BLOOD PRESSURE MONITORING; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; ESSENTIAL HYPERTENSION; FEMALE; HEART RATE; HUMAN; HYPERTENSION; MALE; MEAN ARTERIAL PRESSURE; OBESITY; PRIORITY JOURNAL; SYMPATHETIC TONE;

ADRENERGIC ALPHA-ANTAGONISTS; ADRENERGIC BETA-ANTAGONISTS; ADULT; ATENOLOL; BLOOD PRESSURE MONITORING, AMBULATORY; DOXAZOSIN; FEMALE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; OBESITY; PROSPECTIVE STUDIES; SYMPATHETIC NERVOUS SYSTEM;

EID: 0034956348     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0895-7061(01)01293-6     Document Type: Article

References (24)

1. Epidemic obesity in the United States
2. The relation of adiposity to blood pressure and development of hypertension: The Framingham study
3. Mechanisms of hypertension associated with obesity
4. Body mass index and blood pressure in Korean men and women: The Korean national blood pressure survey
5. Incidence and precursors of hypertension in young adults: The Framingham offspring study
6. Obesity-induced hypertension: Renal function and systemic hemodynamics
7. Cardiovascular regulation in obesity-induced hypertension
8. Hyperinsulinemia: Possible role in obesity-induced hypertension
9. Abnormal kidney function as a cause and a consequence of obesity hypertension
10. Obesity, the sympathetic nervous system, and essential hypertension
11. Pathophysiology of obesity-related hypertension: Role of insulin and the sympathetic nervous system
12. The influence of obesity in hypertension
13. Cardiovascular consequences of obesity: Role of leptin
14. Obesity hypertension - Role of adrenergic mechanisms
15. Clonidine prevents insulin resistance and hypertension in obese dogs
16. Sympathoadrenal activity in human obesity: Heterogeneity of findings since 1980
17. Elevated sympathetic nerve activity in borderline hypertensive humans: Evidence from direct intraneural recordings
18. Neural mechanisms in human obesity-related hypertension
19. Sympathetic activation in obese normotensive subjects
20. Reduced parasympathetic control of heart rate in obese dogs
21. Autonomic nervous system activity in weight gain and weight loss
22. Cardiovascular effects of weight reduction versus antihypertensive drug treatment: A comparative, randomized, 1-year study of obese men with mild hypertension
23. Obesity-related hypertension: Its physiological basis and pharmacological approaches to its treatment
24. Application of prazosin is associated with an increase of insulin sensitivity in obese patients with hypertension